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Introduction
The oncoptrotective properties of exogenous antioxidants
have been documented in a number of epidemiological,
intervention and in vitro studies (for a recent review see
[1]). However, the mechanisms implicated are far from
being clarified. Antioxidant effects, steroid receptor
binding, direct interaction with intracellular elements and
signaling systems and, recently, aryl hydrocarbon receptor
AhR = aryl hydrocarbon receptor; ARNT = aryl hydrocarbon nuclear translocator protein; BSA = bovine serum albumin; DMEM = Dulbecco’s modi-
fied Eagle’s medium; ELISA = enzyme-linked immunosorbent assay; eNOS = endothelial nitric oxide synthase; EROD = ethoxyresorufin-O-de-
ethylase; FBS = fetal bovine serum; IC50 = inhibitory concentration 50%; iNOS = inducible nitric oxide synthase; MTT =
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide; NF = nuclear factor; NO = nitric oxide; NOS = nitric oxide synthase; PAA = 3,4-dihy-
droxy-phenylacetic acid; PBS = phosphate-buffered saline; PCR = polymerase chain reaction; RT = reverse transcriptase.
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Abstract
Introduction The oncoprotective role of food-derived
polyphenol antioxidants has been described but the implicated
mechanisms are not yet clear. In addition to polyphenols,
phenolic acids, found at high concentrations in a number of
plants, possess antioxidant action. The main phenolic acids
found in foods are derivatives of 4-hydroxybenzoic acid and 4-
hydroxycinnamic acid.
Methods This work concentrates on the antiproliferative action
of caffeic acid, syringic acid, sinapic acid, protocatechuic acid,
ferulic acid and 3,4-dihydroxy-phenylacetic acid (PAA) on
T47D human breast cancer cells, testing their antioxidant
activity and a number of possible mechanisms involved
(interaction with membrane and intracellular receptors, nitric
oxide production).
Results The tested compounds showed a time-dependent and
dose-dependent inhibitory effect on cell growth with the
following potency: caffeic acid > ferulic acid = protocatechuic
acid = PAA > sinapic acid = syringic acid. Caffeic acid and
PAA were chosen for further analysis. The antioxidative activity
of these phenolic acids in T47D cells does not coincide with
their inhibitory effect on tumoral proliferation. No interaction
was found with steroid and adrenergic receptors. PAA induced
an inhibition of nitric oxide synthase, while caffeic acid
competes for binding and results in an inhibition of aryl
hydrocarbon receptor-induced CYP1A1 enzyme. Both agents
induce apoptosis via the Fas/FasL system.
Conclusions  Phenolic acids exert a direct antiproliferative
action, evident at low concentrations, comparable with those
found in biological fluids after ingestion of foods rich in
phenolic acids. Furthermore, the direct interaction with the aryl
hydrocarbon receptor, the nitric oxide synthase inhibition and
their pro-apoptotic effect provide some insights into their
biological mode of action.
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(AhR) binding and modification of subsequent signaling
pathways [2–15] have been proposed as possible mecha-
nisms for the mediation of the oncoprotective effect of
these agents. Exogenous antioxidants are exclusively pro-
duced by plants; they are divided into water-soluble
antioxidants (e.g. vitamin C) and lipid-soluble antioxidants
(e.g. vitamin A, vitamin E, β-carotene). In addition, a rich,
heterogeneous class of substances, antioxidant
(poly)phenols, characterized by the presence of one or
multiple phenolic rings in their molecular structure, is also
present in plant sources. This phenolic ring can be
present either in the oxidized form (quinone) or in the
reduced form (phenol). Exogenous antioxidants belong to
distinct classes; for example, simple phenolic acids (e.g.
caffeic acid), phytoalexins (stilbenoids, e.g. resveratrol) or
flavonoids (catechins, quercetin) [16–18]. They further
polymerize and form high molecular weight substances
like tannins.
The majority of studies dealing with antioxidants focuses
on the action of polyphenolic substances. Nevertheless, in
a number of foods, in addition to polyphenols, simple
phenolic acid antioxidants may occur, especially deriva-
tives of 4-hydroxybenzoic acid and 4-hydroxycinnamic acid
[19–21]. Few studies exist on the possible role of pheno-
lic acids in cancer prevention and antigenotoxicity [22].
The present work concentrates on the antiproliferative
action of caffeic acid, syringic acid, sinapic acid, protocat-
echuic acid, ferulic acid and 3,4-dihydroxyphenylacetic
acid (PAA) (Fig. 1) on the human breast cancer T47D cell
line, at concentrations more or less similar to those
expected from normal consumption of foods. Our results
indicate that phenolic acids produce growth inhibition of
cancer cells, in vitro, indicating an additional protective
effect on hormone-dependent breast tumors.
Materials and methods
Cell lines and culture conditions
The hormone-sensitive breast cancer cell line T47D was
purchased from the European Collection of Cell Cultures
(Salisbury, UK). Cells were cultured in DMEM medium,
supplemented with 10% fetal bovine serum (FBS), in a
humidified atmosphere of 5% CO2 in air, at 37°C. Culture
media and serum were from Gibco BRL (Life Technolo-
gies, Paisley, UK). FBS was assayed, prior to use, for the
presence of polyphenol oxidase (seruloplasmin) and trans-
ferrin, by conventional nephelometric techniques, using a
QM300 nephelometer, and commercial kits both by
Kallestad/Pasteur (Paris, France). No measurable levels of
either substance were found in all FBS batches tested.
Cell viability and growth assay
Cells were plated in a 24-well ELISA plate, at an initial
density of 2 × 104 cells, with 1.0 ml medium per well. One
day after seeding (designated as day 0) the medium was
replaced, the different substances were introduced and
the cells were grown for 5 days. Caffeic acid (97% purity),
ferulic acid (99% purity) and protocatechuic acid (99%
purity) were purchased from Aldrich Chemical Co.
(Milwaukee, WI, USA). Sinapic acid (98% purity), syringic
acid (98% purity) and PAA were from Sigma Chemical
Co. (St Louis, MO, USA). Cell growth and viability were
measured by the tetrazolium salt [3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyl tetrazolium bromide (MTT)] assay [23]. All
experiments were performed at least three times, in tripli-
cate. Initial experiments comparing the MTT assay with the
absolute cell number did not show significant differences,
indicating that the MTT assay can be used for the determi-
nation of cell number, even in the presence of antioxidants,
and/or H2O2.
H2O2 treatment
Cells were seeded in 24-well plates at an initial density of
150,000 cells/well. After 24 hours, the medium was
replaced, FBS was omitted and the different phenolic
acids (10–8 M) were introduced. Twenty-four hours later
the culture medium was discarded, and fresh medium
containing different concentrations of H2O2
(0.05–5.0 mM) was provided. After 3 hours at 37°C, cells
were washed in PBS and their viability was determined by
the MTT method, as already described. Although prelimi-
nary experiments did not show any interference of the
serum with H2O2, the serum was eliminated from all the
experiments. Cell viability was not influenced for the short
periods of the experiment by the absence of serum.
Nitric oxide synthase assay
Nitric oxide synthase (NOS) activity was assayed by the
transformation of radioactive arginine to citrulline [24,25].
Briefly, cells were detached from dishes by trypsin-EDTA,
washed with PBS, harvested in PBS–1 mM EDTA, and
homogenized with repeated pipetting with 250 µl homo-
genization buffer (250 mM Tris–EDTA, 10 mM EDTA,
10 mM EGTA). Nuclei and unbroken cells were separated
Figure 1
The phenolic acids used in the present study.
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by centrifugation at 12,000 × g for 15 min and discarded,
while the supernatant was used for the assay of NOS. The
concentration of proteins was adjusted at 10 µg/ml.
A reaction mixture (sufficient for 10 data points) was pre-
pared with 250 µl of 50 mM Tris–HCl (pH 7.4) containing
6 µM tetrahydrobiopterin, 2 µM flavin adenine dinucleotide
and 2 µM flavin adenine mononucleotide, 50 µl of 10 mM
NADPH, 10 µl [3H]arginine (Amersham, Little Chalfont,
UK), 50 µl of 6 mM CaCl2 and 40 µl distilled water. Forty
microliters of this reaction mixture were mixed with 10 µl
protein extract and incubated for 1 hour at 37°C. During
this incubation time [3H]arginine is converted by NOS to
[3H]citrulline. The reaction was stopped with 400 µl ice-
cold 50 mM HEPES (pH 5.5)–5 mM EDTA. Nonreacted
arginine was eliminated by resin absorption (AG 50Wx*;
BioRad Laboratories, Hercules, CA, USA). The eluate was
mixed with scintillation fluid (SigmaFluor; Sigma Chemical
Co.) and the radioactivity was measured in a liquid scintil-
lation counter (Tricarb; Packard Instrument Co., Meriden,
CT, USA), with 60% efficiency for tritium.
Assay for AhR binding and CYP1A1 activity
Cells were plated in 24-well culture dishes (with an initial
density of 150 × 103 cells/well). When the cell culture
reached approximately 70–80% confluency, AhR binding
was performed in serum-free RPMI medium in a total
volume of 0.4 ml. [3H]TCDD (34.7 Ci/mmol; ChemSyn
Laboratories, Lenexa, Kansas, USA) was used in a final
concentration of 5 nM, diluted in dimethyl sulfoxide, while
a 200-fold molar excess of unlabeled TCDD (Wellington
Laboratories, Greyhound, Birkenhead, UK) was used for
nonspecific binding estimation. Phenolic acids were used
with final concentrations ranging from 10–12 to 10–6 M.
The medium was removed after 2 hours of incubation at
37°C in a 5% CO2 atmosphere, and cells were washed
once with ice-cold PBS containing 10% FBS and after-
wards once with cold PBS. Cells were then detached
from dishes with 0.1 ml trypsin–EDTA, and filtered on
Whatman GF/B glass fiber filters (1.0 µm), prewetted in
cold PBS (4°C). The filters were then washed with cold
(–80°C) acetone, allowed to dry and the radioactivity was
measured in a 3 ml scintillation cocktail (SigmaFluor;
Sigma Chemical Co.) using a liquid scintillation counter
(Tricarb; Packard Instrument Co.), with 60% efficiency for
tritium. All measurements were performed in triplicate
[26,27].
The activity of CYP1A1, an enzyme induced by AhR acti-
vation, was assayed by the O-dealkylation of ethoxy-
resorufin (EROD) [26] (Molecular Probes, Leiden, The
Netherlands). Cells were cultured in a black, clear bottom,
96-well plate. When the cells reach 50–60% confluency
5 nM TCDD were added, diluted in dimethyl sulfoxide.
Caffeic acid and PAA (in ethanol) were added at the indi-
cated concentrations. Blank, control and assay wells
received the same amount of dimethyl sulfoxide and
ethanol. After 24 hours of incubation at 37°C in an atmos-
phere of 95% air and 5% CO2, the medium was removed
and the plates frozen sequentially at –20°C, in dry ice and
at –80°C. Afterwards, cells were thawed at room tempera-
ture for 10 min, and BSA (diluted in 50 mM Tris, pH 7.2)
was added at a final concentration of 1.33 µg/ml.
Ethoxyresorufin (diluted in 1.5% methanol in 50 mM Tris,
pH 7.2) was added at a final concentration of 5 µM. The
plates were placed on a plate shaker at 37°C for 15 min.
The EROD reaction was started by adding 1.67 mM
NADPH in 25 µl of 50 mM Tris (pH 7.2). The reaction was
carried out at room temperature for 7 min and stopped by
adding 150 µl ice-cold methanol. The plates were allowed
to sit, at room temperature, for 20–30 min prior to measur-
ing. Fluoerescence was measured at 530 nm excitation
wavelength and 590 nm emission wavelength with a
Microplate Fluorescence Reader FLX800 (Bio-Tech Instru-
ments Inc, Winooski, Vermont, USA). Results were calcu-
lated against a standard curve of resorufin concentration
ranging from 0 to 500 nM (Molecular Probes), diluted in
methanol [27].
Apoptosis assay
Cells treated with 10–7 M phenolic acids for 5 days were
transferred from the culturing wells to a staining tube and
washed with 4 ml PBS, containing 1% BSA, at 4°C. After
medium removal (200 × g for 10 min at 4°C), and washing
of cells with cold PBS, 3 ml cold absolute ethanol were
added, incubated at 4°C for 1 hour, washed twice in cold
PBS, and provided with 1 ml of 50 µg/ml propidium iodide
in 3.8 mM sodium citrate, and 50 µl of 10 µg/ml RNase A
solution. Cells were incubated for 3 hours at 4°C, and
analyzed by flow cytometry, using a Beckton-Dickinson
FACSArray apparatus (Beckton-Dickinson, Franklin Lakes,
NJ, USA) and analyzed with the CELLQuest (Beckton
Dickinson) and ModFit LT (Verify Software, Topsham, MN,
USA) software.
For the double staining, using annexin V and propidium
iodide, cells treated with phenolic acids were transferred
from the culturing wells to a staining tube and washed
with 4 ml PBS, containing 1% BSA, at 4°C. After medium
removal (200 × g for 10 min at 4°C), 100 µl of 2 µg/ml
annexin V–FITC was added, in a staining buffer (10 mM
Hepes, 140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2.5 mM
CaCl2, pH 7.4), and incubated for 10 min in the dark. Pro-
pidium iodide (1 µg/tube) was then added and cells were
analyzed within 20 min by flow cytometry [28].
Semiquantitative western blot analysis of apoptotic
proteins
At the end of each experiment, T47D cells were washed
twice with PBS, removed by scraping and centrifuged at
430 × g. Cell lysis was completed at 4°C by shaking the
pellet vigorously for 30 min reconstituted in a lysis buffer
Available online http://breast-cancer-research.com/content/6/2/R63composed of 50 mM Tris–HCl (pH 8), 150 mM NaCl,
0.1% SDS, 0.5% sodium deoxycholate, 1% NP40 and
freshly added protein inhibitors 10 µg/ml phenylmethylsul-
fonyl fluoride and 1 µg/ml aprotinin. Solid cellular debris
was removed by centrifugation at 12,000 × g for 15 min.
The cytoplasmic fractions were collected and stored at
–80°C.
Protein concentration was measured by the Bio-Rad
Protein Assay Kit II (BioRad Laboratories) following the
instructions of the manufacturer. Samples of cytoplasmic
protein fractions, containing 20 µg protein, were solubi-
lized with SDS-PAGE sample buffer and electrophoresed
through a 12% SDS gel. The resulting protein bands were
transferred to nitrocellulose membranes, using an LKB
electroblot apparatus (LKB, Bromma, Sweden). Standard
western blotting procedures were employed. Band intensi-
ties were quantified by PC-based Image Analysis (Image
Analysis Inc., Ontario, Canada). The antibodies used
were: as primary antibody, anti-human Bcl-2 monoclonal
antibody (clone 124, 1:200; DAKO A/S, Glostrup,
Denmark), the rabbit polyclonal anti-serums against Bax,
Bak, Bcl-xs/l and Bad (1:100; Santa Cruz Biotechnology,
Inc., CA, USA), the anti-Fas (1:2500) and anti-FasL
(1:1000; Transduction Laboratories, Lexington, KY, USA);
and as secondary antibody, goat peroxidase-conjugated
anti-mouse IgG (1:10,000; Chemicon International Inc.,
CA, USA) or anti-rabbit IgG (1:4000; Immunotech, Mar-
seille, France). For purposes of normalization the blots
were also stained with a monoclonal anti-actin antibody in
a dilution of 1:400 (Amersham).
RT-PCR assays
NOS and CYP1A1 transcripts were measured by semi-
quantitative multiplex RT-PCR versus the constitutive gene
of actin. Cells were cultured in six-well plates 24 hours
prior to the addition of phenolic acids. Samples were
taken after 2, 6, 12 and 24 hours of treatment. Total RNA
was extracted with TRIzol® reagent (Invitrogen, Carisbad,
CA, USA) according to the manufacturer’s protocol, with
an additional step of 70% ethanol wash.
For the RT reaction 1 µg RNA was used. First, DNA was
eliminated with DNase I amplification grade treatment
(Invitrogen) for 20 min at 25°C, followed by heat inactiva-
tion for 10 min at 65°C. Then cDNA synthesis was per-
formed using SuperScript™ II RNA H– reverse trascriptase
(Invitrogen), 5 µM poly d(T) (Amersham Pharmacia
Biotech) and 1 µl ribonuclease inhibitor rRNasin®
(Promega, Madison, WI, USA), in a total volume of 20 µl,
for 1 hour at 42°C, which was stopped after incubation for
5 min at 95°C.
Multiplex PCR reactions were performed using 1 µl cDNA
product, the DNA primers, 200 µM each dNTP (Invitro-
gen) and 1 U DyNAzyme II polymerase (Finzyme, Ozyme,
France) in a total volume of 25 µl for 35 cycles, with a 30 s
extension period. The specific set of DNA primers (MWG
Biotech, Ebersberg, Germany), all in a concentration of
500 nM, and annealing temperatures used were: endothelial
nitric oxide synthase (eNOS) (forward, 5′-AATCCTGTA-
TGGCTCCGAGA-3′ and reverse, 5′-GGGACACCACGT-
CATACTCA-3′) at 58.3°C, inducible nitric oxide synthase
(iNOS) (forward, 5′-ACAGGAGGGGTTAAAGCTGC-3′
and reverse, 5′-TTGTCTCCAAGGGACCAGG-3′) at
59.1°C, and CYP1A1 (forward, 5′-CTCTTAGGT-
GCTTGAGAGCCC-3′ and reverse, 5′-CATCAGCA
TCTATGTGGCCC-3′) at 60°C. Actin primers (forward,
5′-GGTGGCTTTTAGGATGGCAAG-3′ and reverse, 5′-
ACTGGAACGGTGAAGGTGACA-3′) were added to the
PCR mix at a concentration of 100 nM and 250 nM, for
eNOS and iNOS or for CYP1A1, respectively. PCR prod-
ucts were electrophorized in 3% agarose gel in 0.5 × TBE
buffer at 100 mV, in a horizontal apparatus (Horizon®
11-14; Life Technologies, Gibco BRL, Goettingen,
Germany) and band intensities were measured using the
Molecular Analyst Software (BioRad).
Statistical analysis
Statistical analysis was performed by parametric methods,
with the aid of the microcomputer programs Origin V 5.0
(Microcal Software, Northampton, MA, USA) and Systat V
10.0 (SPSS, Chicago, IL, USA).
Results
Phenolic acids affect the proliferation of T47D cells
All tested phenolic acids showed a time-dependent
(Fig. 2a) and a dose-dependent inhibition of cell growth
(Fig. 2b). The maximum effect was observed on the 5th
day of incubation (two proliferation cycles). Caffeic acid
was the most potent inhibitor of cell growth [inhibitory
concentration 50% (IC50) = 2.17 × 10–9 M]. The number
of cells remained unchanged after two or three prolifera-
tion cycles (20%, as compared with the control). This
effect was also obvious in the time-course curves.
A second group of the phenolic acids is composed of
ferulic acid, protocatechuic acid and PAA. All three com-
pounds inhibited cell growth by 40%, showing one-half of
the potency of caffeic acid. Of these, PAA was the most
potent inhibitor, with IC50 <10 –12 M, followed by protocat-
echuic acid (IC50 =  2×1 0 –11 M) and ferulic acid (IC50 =
2 . 3×1 0 –9 M). Finally, sinapic acid and syringic acid were
only partial inhibitors of cell growth, decreasing cell prolif-
eration by 20%, with IC50 values ranging from 7 × 10–11 M
(sinapic acid) to <10–12 M (syringic acid).
Considering the time effect, three different groups of com-
pounds are depicted. Caffeic acid has a proper time effect
with a half-life of 3.2 days. Sinapic acid, syringic acid, pro-
tocatechuic acid and PAA have the same time effect with
a half-life of 1.1 days, but with a different final effect, as
Breast Cancer Research    Vol 6 No 2 Kampa et al.
R66described for the dose effect. Finally, ferulic acid shows a
biphasic effect, with a short time effect comparable with
that of sinapic acid and syringic acid, and a longer lasting
effect similar to these of protocatechuic acid and PAA.
This is better seen in the inset of Fig. 2a, which depicts
the logit of the inhibition of cell growth on the ordinate,
and the log2 of the incubation time on the abcissa.
In conclusion, all tested phenolic acids produced a signifi-
cant inhibition of T47D cell proliferation, with IC50 values
ranging from the nanomolar to the picomolar range. The
concentration of 10–7 M was thus chosen for the following
experiments, corresponding in all cases to the maximum
effective concentration.
We then focused on two out of the six substances: caffeic
acid (i.e. the major effective antiproliferative compound;
Fig. 2) and PAA (the precursor molecule for the synthesis
of the other more complex phenolic molecules) [29].
Effect of phenolic acids in the cell cycle and apoptosis
Figure 3a presents the effect of 48 hours of incubation
with 10–7 M caffeic acid and PAA on the cell cycle. As
shown, apparent apoptosis is obvious after PAA incuba-
tion, a result found equally when cells were stained with
annexin V and propidium iodide (Fig. 3c). The analysis
of cell cycle phases, presented in Fig. 3b, indicates that
the number of nonapoptotic cells in the G0/G1 phase is
significantly decreased after caffeic acid incubation. In
contrast, both phenolic acids decrease the number of
cells in the G2/M phase, and increase the S phase of
T47D cells.
Apoptosis can be distinguished at early stages by the
exposure of phosphatidylserine moieties on cell mem-
branes, identified by annexin V binding, while late apopto-
sis is characterized by the appearance of DNA
fragmentation. Figure 3c depicts early and late apoptosis in
T47D cells, produced 5 days after the application of caffeic
Available online http://breast-cancer-research.com/content/6/2/R63
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Figure 2
Time effect and dose effect of phenolic acids on the proliferation of T47D breast cancer cells. (a) Cells (2 × 104) were seeded in 24-well culture
plates, and incubated for the indicated number of days with 10–8 M of different phenolic acids. In another series of experiments, cells were cultured
in the absence of phenolic acids. The figure presents the ratio of the cell number in the presence/absence of the different phenolic acids. A typical
experiment is presented, which was performed three more times with similar results. Inset: Data presented in the figure were analyzed by the
application of the exponential decay equation y = y0 + A1e–(x–x0)/t, in which y is the observed ratio of the cell number in the presence/absence of the
phenolic acid, y0 is the maximal observed decrease of cell proliferation (plateau), A1 is 1 – y0, x0 is the initial time of observation (= 0), and x is the
time (in days) of the y observation (abscissa of the y observation). The equation after transformation is rearranged as ln [(y – y0)/( 1–y0) ]=– xt, the
left side of which is the logit of the earlier quantity. From this equation one can obtain the calculation of t, which is an estimate of the half-life (t1/2) of
the effect of the applied agent. In the case of the monotonous curves (sinapic acid, syringic acid, protocatechuic acid, and 3,4-dihydroxy-phenylacetic
acid), this t1/2 was varying between 0.9 and 1.3 days. In the case of ferulic acid, in which the observed curve follows that of sinapic acid and ferulic
acid for short incubation times and jumps to that of protocatechuic acid and 3,4-dihydroxy-phenylacetic acid for longer incubation times, the
calculated t1/2 was 5.7 days. Finally, for caffeic acid, in which a sigmoidal curve was observed, data were not well fitted to the curve and the
calculated t1/2 was 4.1 days. (b) Dose effect of phenolic acids on T47D cell proliferation. Cells (2 × 104) were incubated for 5 days in the absence
or the presence of the indicated concentrations of phenolic acids, ranging from 10–12 to 10–6 M. The figure presents the ratio of the number of
cells in the presence/absence of the indicated phenolic acids. A typical experiment is presented, repeated three more times with similar results.
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Ln2 (Day)acid and PAA. Both phenolic acids induced apoptosis after
5 days of incubation. Necrotic cells were constantly low,
indicating that these substances are not cytotoxic, at least
at the concentrations used. It is interesting to note that,
even at long incubation times (5 days), the main finding is
early apoptotic changes. In addition, the effect of PAA was
more prominent than that of caffeic acid.
Analysis of apoptotic-related proteins is depicted in
Fig. 3d. Both phenolic acids (caffeic and PAA) induced
significantly the anti-apoptotic protein Bcl-2 (3.3-fold and
2.8-fold, respectively). In addition, the pro-apoptotic FasL
protein was induced by caffeic acid (1.6-fold). In contrast,
the same phenolic acid decreased significantly the levels
of the anti-apoptotic Bcl-xl protein. PAA, on the contrary,
decreased significantly the levels of the pro-apoptotic pro-
teins Bak and Fas, indicating different signaling pathways
leading to apoptosis.
Phenolic acids have been reported to have an intrinsic
free radical scavenging and antioxidant activity. In many in
vitro systems, PAA was reported to be the strongest
antioxidant, followed by caffeic acid [30]. In order to
explore the possibility that phenolic acids might exert
their antiproliferative action on T47D cells acting as
antioxidants, we have incubated these cells with phenolic
acids (10–7 M), and exposed them, after 24 hours, to
varying concentrations of H2O2. As shown in Fig. 4, PAA
produced a significant shift to the effective dose 50%
value of H2O2. In contrast, caffeic acid, which exhibited
the stronger antiproliferative effect on this cell system, did
not show any notable antioxidant activity.
Mechanism of action of phenolic acids in breast cancer
cells
It appears that wine flavonoids and stilbens show an inter-
action with steroid hormone receptors in T47D cells [31].
We therefore tested phenolic acids for a similar interaction
and also for a possible interaction with adrenergic recep-
tors, reported to be implicated in prostate cancer cell
growth arrest [32]. Finally, we examined the interaction of
phenolic acids with the NOS system, also known to be
involved in the cellular action of wine antioxidants [33]. In
contrast to wine polyphenols [31], however, no interaction
Breast Cancer Research    Vol 6 No 2 Kampa et al.
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Figure 3
Effect of caffeic acid and 3,4-dihydroxy-phenylacetic acid (PAA) on the cell cycle and apoptosis after long (two cell cycles) incubation times. Cells
were incubated with the indicated phenolic acids for 5 days. The medium, containing 10–7 M of the agents, was changed every other day. At the
end of the incubation period, cells were removed from plates by scraping, stained with annexin V and/or propidium iodide (PI), as described in
Materials and methods, and analyzed by flow cytometry. Early apoptotic changes were identified as the cell population having a normal (diploid)
DNA content and annexin V staining. Late apoptotic cells were those presenting a hypodiploid DNA content identified by PI staining. After
permeabilization of cells, staining with PI and flow cytometry revealed cell cycle phases. Necrotic cells were identified by forward and side scatter.
(a) Typical flow cytometric analysis of the cell cycle. Cells were stained with PI. (b) Cumulative cell cycle phases of nonapoptotic cells
(mean ± standard error of the mean of three measurements). (c) Cumulative effects of phenolic acids on apoptosis (mean ± standard error of the
mean of three experiments). Cells were stained with annexin V and PI. (d) Effect of phenolic acids on apoptosis-related proteins. Semiquantitative
western blot analysis on cell homogenates from T47D cell cultures treated with 10–7 M various phenolic acids for 5 days. At the end of the
incubation period, cells were removed from plates by scraping and apoptosis-related proteins were measured with western blot analysis, as
described in Materials and methods. Quantification results are depicted, expressed as the percentage of nontreated control values. Data are
mean ± standard error of the mean of three independent experiments.of either phenolic acid with estrogen, progesterone or
adrenergic receptors was found (data not shown).
Previous reports from our group show that a number of
polyphenolic antioxidants interact with the NOS-producing
system [33]. Our data, presented in Fig. 5, indicate that, in
cellular homogenates of T47D cells, PAA directly
decreased NOS activity by 40%, while caffeic acid did not
show any notable inhibition. In contrast, RT-PCR assays of
the two isoforms of NOS (eNOS and iNOS) after variable
incubation times showed that PAA transiently increased
iNOS transcription (within 2 hours), followed by a 50%
decrease. Meanwhile, eNOS transcription was reduced by
50%. A normalization occurs thereafter, followed by a
linear decrease at longer incubation times.
Another receptor–effector system that recently gained
increased attention is the AhR system. The interaction of
several antioxidants with the AhR has already been estab-
lished. Resveratrol, a stilbene found in red wine, appears
to be a pure AhR competitive antagonist [34]. It appears
that quercetin and kaempferol regulate CYP1A1 gene
expression through binding to the AhR [8,9]. We therefore
tested the possible interaction of caffeic acid and PAA
with this receptor system. As shown in Fig. 6a, only caffeic
acid displaced radiolabeled TCDD from the AhR, with an
IC50 value of 158 nM (Fig. 6b) comparable with that of the
prototype ligand. This effect is 100 times higher compared
with the cell growth inhibition by caffeic acid (2.17 nM).
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Figure 4
Effect of phenolic acids on the inhibition of H2O2 cytotoxicity. (a) Cells
(15 × 104) were incubated for 24 hours with the different phenolic
acids (10–7 M). The medium was then discarded and replaced with a
fresh one, in which fetal bovine serum was omitted, containing the
indicated concentrations of H2O2. Incubation was followed for 3 hours,
and then the viability of cells was determined by the MTT method.
Results are presented of an experiment (in triplicate) performed four
times with similar results. (b) The difference of effective concentration
50% values of H2O2 obtained in the presence of phenolic acids, as
compared with control experiments. Bars represent the standard error
of the mean of four different experiments performed in triplicate. IC50,
inhibitory concentration 50%; PAA, 3,4-dihydroxy-phenylacetic acid.
Figure 5
(a) Effect of 24 hours of incubation with phenolic acids (10–7 M) on
the activity of nitric oxide synthase (NOS) in the cytoplasm of T47D
cells. (b) Time course of the effect of 3,4-dihydroxy-phenylacetic acid
(PAA) (10–7 M) on the transcript of endothelial nitric oxide synthase
(eNOS) and inducible nitric oxide synthase (iNOS). RT-PCR data for
either enzyme were normalized for actin, and divided by the
corresponding control values (control = 1 in all cases).Activation of the AhR leads to a nuclear translocation, an
association with specific transcription factors (aryl hydro-
carbon nuclear translocator protein [ARNT]) and a modifi-
cation of CYP1A1 expression. In order to identify whether
the association of caffeic acid with the AhR is agonistic or
antagonistic, we have assayed both the activity of
CYP1A1 with the EROD method [26], and the CYP1A1
transcript with RT-PCR. As depicted in Fig. 6c, the inter-
action of caffeic acid with the AhR resulted in an inhibition
of basal and TCDD-stimulated activity of CYP1A1. The
observed IC50 value for this inhibition was 10.8 nM
(Fig. 6d). This inhibitory effect was partial (maximum inhibi-
tion, 25%). In order to discriminate between a direct
action of caffeic acid on the enzyme and a modification of
transcription, we performed a time course of the CYP1A1
transcript with RT-PCR. Basal levels of CYP1A1 transcript
were inhibited by 70% after 24 hours of incubation
(Fig. 6e,f). In parallel, a weak effect of TCDD-stimulated
CYP1A1 transcription was observed.
Discussion
A great number of reports have in recent years dealt with
antioxidants and their action on cancer cell proliferation
(for a recent review see [1]). The great majority of these
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Figure 6
Interaction of phenolic acids with the aryl hydrocarbon receptor (AhR). (a) Interaction of 10–7 M phenolic acids on the AhR against TCDD. 
(b) Competition of caffeic acid on aryl hydrocarbon binding. Homologous displacement with TCDD given for comparison. (c) Inhibition of basal and
TCDD-stimulated CYP1A1 (O-dealkylation of ethoxyresorufin [EROD]) activity by 10–7 M caffeic acid. (d) Dose effect of caffeic acid on the
(EROD) activity of CYP1A1, after 24 hours of incubation. The time course of (e) the basal and (f) the TCDD-stimulated CYP1A1 transcript, after
application of 10–7 M caffeic acid. RT-PCR data were normalized for actin, and divided by the corresponding control values (control = 1 in all
cases). PAA, 3,4-dihydroxy-phenylacetic acid.studies have been targeted towards polyphenolic antioxi-
dants, active in chronic degenerative diseases, including
cardiovascular diseases and cancer. In contrast, phenolic
acids were overlooked in spite of the fact that these sub-
stances are found in appreciable concentrations in an
important number of vegetable foods [19–22] (for a
recent review see [29]). The present study investigated
the antiproliferative action of these simple phenolics on
cell proliferation of the hormone-sensitive T47D breast
cancer cell line. The choice of the phenolic acids was
based on their concentration in a number of plant foods,
and on the fact that some of these phenolic acids (e.g.
PAA) are precursors of more complex (poly)phenolic mol-
ecules [29].
Our data showed that all six phenolic acids tested
possess a dose-dependent and time-dependent inhibitory
antiproliferative effect on T47D cells. Nevertheless, a dif-
ferential effect for each phenolic acid was found, with IC50
values varying from the nanomolar to the picomolar range.
The time course of phenolic acids varies equally. Indeed,
caffeic acid exerts its action later than other phenolic
acids, suggesting a different mode of action. Ferulic acid,
structurally related to caffeic acid, shows a bimodal effect,
with a short time component and a long time component.
Finally, all other phenolic acids show a half-maximal effect,
achieved after 2 days. Comparing the structures of the dif-
ferent phenolic acids, presented in Fig. 1, our data
suggest that the two hydroxyl groups on the phenolic ring
and the three carbon side chains are both essential for the
antiproliferative activity. The shortening of the side chain
produces a loss of the antiproliferative activity, which is
more apparent in both the methylation of one or both –OH
group(s) and the p-OH substitution found in syringic acid
and sinapic acid. In addition, shortening of the side chain
confers an increased IC50 value, indicating a possible
increase of the transmembrane transit of the compounds
or, alternatively, an increased interaction with an unknown
membrane constituent.
To examine the possible mode of action of simple phenolic
acids on T47D cell growth, we have concentrated on two
out of the six phenolic acids: caffeic acid, which is the
most potent, and PAA, which is a precursor for the synthe-
sis of other more complex molecules [29]. Furthermore,
we have tested low concentrations of these phenolic
acids comparable with those found in the body after con-
sumption of foods. In contrast to polyphenols [31], we
have not detected any interaction of these two com-
pounds with either estrogen, progesterone or adrenergic
receptors in T47D cells. Cell cycle analysis revealed that
phenolic acids increase the number of nonapoptotic cells
in the S phase and decrease the G2/M phase of the cell
cycle. In addition, both substances induced apoptosis
within 5 days. PAA appears to be a more potent inducer of
apoptosis than caffeic acid (Fig. 3).
Phenolic acids were reported to possess a major antioxi-
dant activity in different systems [30]. We have therefore
investigated whether the antiproliferative and pro-apop-
totic effects of caffeic acid and PAA were correlated with
their inhibition of H2O2 toxicity, an indirect measurement of
their antioxidant activity. A differential effect between
caffeic acid and PAA was found (Fig. 4a,b). Indeed,
caffeic acid did not show any notable shift of the H2O2-
induced toxicity (IC50 = 0.28 mM, as compared with
IC50 = 0.51 mM of control cells). In contrast, PAA pro-
duced a major (two logarithms) shift of the H2O2 curve
(IC50 = 67.01 mM). It is interesting to note that PAA
decreased the activity of NOS, and concomitantly
decreased the possible production of endogenous reac-
tive nitrogen species.
The role of nitric oxide (NO) in cancer is ubiquitous (for a
discussion see [35]). NO was reported to inhibit cell pro-
liferation, to induce differentiation and to decrease the
metastatic spread of different tumor cell lines [36],
although this effect seems to be related to the type and
the origin of the cancer cell studied [37], and to the oxida-
tive status of the cells [38,39]. Polyphenols have been
reported to affect NO production [40] and some of its bio-
logical effects [41,42]. Although the role of the NO/NOS
system in breast cancer is controversial (for a review of
the current bibliography see, for example, [43]), inhibition
of NOS activity has been considered a possible target for
anticancer treatment. In MCF7 breast cancer cells,
inhibitors of NO synthesis (NG-nitro-L-arginin methyl ester)
and NO scavengers induced apoptosis [44], via a p53-
associated pathway, while in T47D cells suppression of
NO production triggers an induction of apoptosis via a
FKHRL1 (FOXO3a) kinase pathway, independent of phos-
phoinositide 3-kinase-Akt and caspase 3 activation [45].
In this respect, the decrease in NOS activity by PAA could
explain its pro-apoptotic effect (Fig. 5). It is further interest-
ing to note that, in addition to the inhibition of enzyme
activity, PAA decreases NOS transcripts after long
(>12 hours) incubation times. At shorter incubation times,
however, a substantial increase of iNOS was found, indi-
cating differential regulation of transcription.
Caffeic acid conversely seems to modify cell proliferation
through interaction with the xenobiotic receptor
(AhR)–CYP system. The aryl hydrocarbon or xenobiotic
receptor (AhR) is a ligand-activated nuclear transcription
factor that binds structurally diverse environmental conta-
minants (for a recent review see [46]). Upon ligand
binding, the AhR translocates to the nucleus and het-
erodimerizes with the ARNT [47,48]. The AhR–ARNT het-
erodimer binds to dioxin (or xenobiotic) responsive
elements of genes encoding xenobiotic-metabolizing
enzymes such as CYP1A1, CYP1A2, CYP1B1, glu-
tathione S-transferase, UDP-glucuronosyltransferase1A6,
and NAD(P)H quinone oxidoreductase-1 [49–51]. It is
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sive element has been discovered at the regulatory region
of the latter three enzymes (reviewed in [52]). ARNT, on
the contrary, appears to be a common dimerization partner
for many nuclear transcription factor proteins [53–58],
most probably playing the role of crosstalk integrator
between diverse signaling pathways.
In addition to the induction of xenobiotic-metabolizing
enzymes, the AhR may have other pleiotropic actions.
Indeed, the AhR is involved in cell cycle regulation
(through interaction with c-myc, p53 Rb and other cycle
regulating elements), in induction of phase II metabolizing
enzymes, in antioxidant response, and in induction of pro-
apoptotic or anti-apoptotic genes (reviewed in [52]).
Direct and/or indirect interactions of the AhR and NF-κB
transcription factors have been reported (reviewed in
[59]). In this respect, modification of NF-κB levels may
modify the concentration of a number of apoptotic-related
factors. Our results suggest that caffeic acid may bind to
the AhR, being an inhibitor of its action, thus decreasing
the transcription and activity of CYP1A1, both in basal
and TCDD-treated cells. This implies either a direct effect
on the enzyme molecule or a competition for the AhR with
the (at present unknown) endogenous ligand of the AhR
[52]. This latter hypothesis seems more probable as, in
our experimental conditions, the same inhibitory pattern
was found in either case (20% decrease). To our knowl-
edge, this is the first report indicating an interaction of
phenolic acids with the AhR.
It was recently shown that the effect of TCDD is exerted
via binding to AhR. AhR–TCDD complex in turn induces
CYP1A1 [15], resulting in a significant increase in the
DNA binding activity of NF-κB and apolipoprotein 1, and a
sustained activation of these two transcription factors. It is
of note that this activation was blocked by antioxidants
[15]. On the contrary, activation of the Fas receptor
induces the phosphorylation of NF-κB transcription factor,
resulting in induction of apoptosis in a number of various
cell types [60,61]. Considering the role of NF-κB in
cancer cell apoptosis [62], it is tentative to hypothesize
that caffeic acid may act by inhibiting this pathway. This
hypothesis is further supported by the stimulation effect of
caffeic acid on pro-apoptotic Fas receptor.
In an effort to uncover other pathways of apoptosis,
involved in the pro-apoptotic actions of phenolic acids on
T47D cells, we have also tested their effects on the
members of the other major family of apoptosis-related
factors, the Bcl-2 proteins. Bcl-2 proteins are strongly
expressed in human breast cancer cells, including the
T47D cells [63]. Surprisingly, both phenolic acids ele-
vated the protein content of the apoptosis-preventing Bcl-
2 protein. It is possible that a Bcl-2-related mechanism is
activated to short-term counteract the stress signals gen-
erated by the apoptosis-inducing factor FasL in order to
rescue the cells from programmed death. Another possi-
bility is that Bcl-2 related anti-apoptotic proteins, at the
outer mitochondrial membrane, increased to counteract
the pro-oxidant effects of phenolic acids locally [64].
Conclusions
The present work suggests that phenolic acids exert a
direct antiproliferative action. This action is evident at low
concentrations, comparable with those found in biological
fluids after ingestion of foods rich in phenolic acids. Fur-
thermore, the direct interaction with the AhR (caffeic acid),
the interaction with the NOS system (PAA) and the pro-
apoptotic effect of phenolic acids provide insights about
their mode of action.
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